Search Results - Komrskova, K.

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    17α-Ethynylestradiol alters testicular epigenetic profiles and histone-to-protamine exchange in mice

    17α-Ethynylestradiol alters testicular epigenetic profiles and histone-to-protamine exchange in mice by Ded, L, Zatecka-Lanska, E, Vaculikova, E, Frolikova, M, Sanovec, O, Palenikova, V, Simonik, O, Dorosh, A, Margaryan, H, Elzeinova, F, Kubatova, A, Peknicova, J, Paradowska-Dogan, A, Steger, K, Komrskova, K

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  2. 2
    Expression and distribution of CD151 as a partner of alpha6 integrin in male germ cells

    Expression and distribution of CD151 as a partner of alpha6 integrin in male germ cells by Jankovicova, J., Frolikova, M., Palenikova, V., Valaskova, E., Cerny, J., Secova, P., Bartokova, M., Horovska, L., Manaskova-Postlerova, P., Antalikova, J., Komrskova, K.

    Published in Scientific reports
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    17[alpha]-Ethynylestradiol alters testicular epigenetic profiles and histone-to-protamine exchange in mice

    17[alpha]-Ethynylestradiol alters testicular epigenetic profiles and histone-to-protamine exchange in mice by Ded, L, Zatecka-Lanska, E, Vaculikova, E, Frolikova, M, Sanovec, O, Palenikova, V, Simonik, O, Dorosh, A, Margaryan, H, Elzeinova, F, Kubatova, A, Peknicova, J, Paradowska-Dogan, A, Steger, K, Komrskova, K

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

    Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial by Home, Philip D, Prof, Pocock, Stuart J, Prof, Beck-Nielsen, Henning, Prof, Curtis, Paula S, PhD, Gomis, Ramon, Prof, Hanefeld, Markolf, Prof, Jones, Nigel P, MA, Komajda, Michel, Prof, McMurray, John JV, Prof

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Efficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetes

    Efficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetes by Fulcher, G., Matthews, D. R., Perkovic, V., de Zeeuw, D., Mahaffey, K. W., Mathieu, C., Woo, V., Wysham, C., Capuano, G., Desai, M., Shaw, W., Vercruysse, F., Meininger, G., Neal, B.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: